These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6442468)

  • 21. A two-site, monoclonal antibody-based immunoassay for von Willebrand factor--demonstration that vWF function resides in a conformational epitope.
    Chand S; McCraw A; Hutton R; Tuddenham EG; Goodall AH
    Thromb Haemost; 1986 Jun; 55(3):318-24. PubMed ID: 2428124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoradiometric measurement of the factor VIII procoagulant antigen.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.
    Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ
    J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
    Dahl CJ; McRoyan DK; Liu PI
    Ann Clin Lab Sci; 1983; 13(5):371-8. PubMed ID: 6416137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS; Abildgaard CF; Meyer D
    N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the effects of five monoclonal antibodies, polyclonal rabbit antibody and homologous antibody to human F VIII/vWF on ristocetin-induced platelet agglutination and platelet retention by glass bead column].
    Ogata K; Minami S; Kamiya T
    Rinsho Ketsueki; 1985 Jul; 26(7):1042-9. PubMed ID: 2414486
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of von Willebrand's disease by means of the quantitative immunological assay of factor VIII-related antigen (author's transl)].
    Gruson R; Kernoff PB
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1593-5. PubMed ID: 4210557
    [No Abstract]   [Full Text] [Related]  

  • 32. Von Willebrand's syndrome. Studies on a variant factor VIII.
    Hill FG; Chan MC; Hardisty RM
    Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
    Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
    Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence.
    Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM
    Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radioimmunoassay of antihemophilic factor A].
    Strike L; Saint Paul B; Chassaigne M; Allain JP
    Nouv Presse Med; 1976 Dec; 5(42):2877-9. PubMed ID: 1087007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
    [No Abstract]   [Full Text] [Related]  

  • 38. A rapid one-step immunoradiometric assay for factor VIII-procoagulant antigen utilizing monoclonal antibodies.
    Stel HV; Veerman EC; Huisman JG; Janssen MC; van Mourik JA
    Thromb Haemost; 1983 Dec; 50(4):860-3. PubMed ID: 6420924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The diagnostic characteristics of von Willebrand's disease].
    Golovina OG; Papaian LP; Beliazo OE; Khrolova PV; Lavrichenko IA; Andreeva TA; Khanina TM
    Ter Arkh; 1996; 68(4):58-61. PubMed ID: 9324795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.